Lexicon Pharmaceuticals
LXRX
#6564
Rank
โ‚น85.80 B
Marketcap
โ‚น192.84
Share price
1.52%
Change (1 day)
95.91%
Change (1 year)

Lexicon Pharmaceuticals (LXRX) Fails to deliver data

Key failure to deliver metrics for Lexicon Pharmaceuticals :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Lexicon Pharmaceuticals (LXRX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Lexicon Pharmaceuticals (LXRX) - since 2015

Volume in USD (price x number of shares), data since 2015

Lexicon Pharmaceuticals (LXRX) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026โ‚น1.91 M-84.64%
2025โ‚น12.43 M-38.43%
2024โ‚น20.19 M111.04%
2023โ‚น9.57 M315.88%
2022โ‚น2.3 M-91.22%
2021โ‚น26.2 M1.63%
2020โ‚น25.78 M21.18%
2019โ‚น21.27 M-6.95%
2018โ‚น22.86 M-27.5%
2017โ‚น31.53 M18.35%
2016โ‚น26.64 M59.83%
2015โ‚น16.67 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Thermo Fisher Scientific
TMO
โ‚น42.4 Mโ‚น71.86 M๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚น63.08 Mโ‚น88.35 M๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚น4.21 Mโ‚น15.54 M๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
โ‚น5.42 Mโ‚น10.37 M๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น7.4 Mโ‚น17.74 M๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
โ‚น1.41 Mโ‚น22.59 M๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
N/Aโ‚น0.94 M๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น2.84 Mโ‚น16.47 M๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
N/Aโ‚น4.61 M๐Ÿ‡บ๐Ÿ‡ธ USA